Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Bronchiectasis Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Bronchiectasis Treatmentmarket, defines the market attractiveness level of Bronchiectasis Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Bronchiectasis Treatment industry, describes the types of Bronchiectasis Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bronchiectasis Treatment market and the development prospects and opportunities of Bronchiectasis Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bronchiectasis Treatment market in Chapter 13.
By Player:
Alitair Pharmaceuticals Inc
Grifols SA
Bayer AG
Chiesi Farmaceutici SpA
Recipharm AB
Insmed Inc
Kamada Ltd
GlaxoSmithKline Plc
Polyphor Ltd
By Type:
Amikacin Sulfate
ARD-3150
CHF-6333
Ciprofloxacin Hydrochloride
Doxofylline
Others
By End-User:
Clinic
Hospital
Homecare
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Bronchiectasis Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Bronchiectasis Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Bronchiectasis Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Bronchiectasis Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Bronchiectasis Treatment Market Analysis and Outlook to 2022
-
7.1 Global Bronchiectasis Treatment Consumption (2017-2022)
-
7.2 United States Bronchiectasis Treatment Consumption (2017-2022)
-
7.3 Europe Bronchiectasis Treatment Consumption (2017-2022)
-
7.4 China Bronchiectasis Treatment Consumption (2017-2022)
-
7.5 Japan Bronchiectasis Treatment Consumption (2017-2022)
-
7.6 India Bronchiectasis Treatment Consumption (2017-2022)
-
7.7 South Korea Bronchiectasis Treatment Consumption (2017-2022)
8 Region and Country-wise Bronchiectasis Treatment Market Analysis and Outlook to 2028
-
8.1 Global Bronchiectasis Treatment Consumption Forecast (2022-2028)
-
8.2 United States Bronchiectasis Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Bronchiectasis Treatment Consumption Forecast (2022-2028)
-
8.4 China Bronchiectasis Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Bronchiectasis Treatment Consumption Forecast (2022-2028)
-
8.6 India Bronchiectasis Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Bronchiectasis Treatment Consumption Forecast (2022-2028)
9 Global Bronchiectasis Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Bronchiectasis Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Amikacin Sulfate Consumption and Growth Rate (2017-2022)
-
9.1.2 Global ARD-3150 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global CHF-6333 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Ciprofloxacin Hydrochloride Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Doxofylline Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Bronchiectasis Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Homecare Consumption and Growth Rate (2017-2022)
10 Global Bronchiectasis Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Bronchiectasis Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Amikacin Sulfate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global ARD-3150 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global CHF-6333 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Ciprofloxacin Hydrochloride Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Doxofylline Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Bronchiectasis Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Homecare Consumption Forecast and Growth Rate (2022-2028)
11 Global Bronchiectasis Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Bronchiectasis Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Bronchiectasis Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Bronchiectasis Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Bronchiectasis Treatment Market Competitive Analysis
-
14.1 Alitair Pharmaceuticals Inc
-
14.1.1 Alitair Pharmaceuticals Inc Company Details
-
14.1.2 Alitair Pharmaceuticals Inc Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Alitair Pharmaceuticals Inc Bronchiectasis Treatment Product and Service
-
14.2 Grifols SA
-
14.2.1 Grifols SA Company Details
-
14.2.2 Grifols SA Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Grifols SA Bronchiectasis Treatment Product and Service
-
14.3 Bayer AG
-
14.3.1 Bayer AG Company Details
-
14.3.2 Bayer AG Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bayer AG Bronchiectasis Treatment Product and Service
-
14.4 Chiesi Farmaceutici SpA
-
14.4.1 Chiesi Farmaceutici SpA Company Details
-
14.4.2 Chiesi Farmaceutici SpA Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Chiesi Farmaceutici SpA Bronchiectasis Treatment Product and Service
-
14.5 Recipharm AB
-
14.5.1 Recipharm AB Company Details
-
14.5.2 Recipharm AB Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Recipharm AB Bronchiectasis Treatment Product and Service
-
14.6 Insmed Inc
-
14.6.1 Insmed Inc Company Details
-
14.6.2 Insmed Inc Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Insmed Inc Bronchiectasis Treatment Product and Service
-
14.7 Kamada Ltd
-
14.7.1 Kamada Ltd Company Details
-
14.7.2 Kamada Ltd Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Kamada Ltd Bronchiectasis Treatment Product and Service
-
14.8 GlaxoSmithKline Plc
-
14.8.1 GlaxoSmithKline Plc Company Details
-
14.8.2 GlaxoSmithKline Plc Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GlaxoSmithKline Plc Bronchiectasis Treatment Product and Service
-
14.9 Polyphor Ltd
-
14.9.1 Polyphor Ltd Company Details
-
14.9.2 Polyphor Ltd Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Polyphor Ltd Bronchiectasis Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Bronchiectasis Treatment
-
Figure Bronchiectasis Treatment Picture
-
Table Global Bronchiectasis Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bronchiectasis Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bronchiectasis Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Bronchiectasis Treatment Consumption by Country (2017-2022)
-
Figure United States Bronchiectasis Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Bronchiectasis Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Bronchiectasis Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Bronchiectasis Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Bronchiectasis Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bronchiectasis Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Bronchiectasis Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Bronchiectasis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bronchiectasis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Bronchiectasis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bronchiectasis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bronchiectasis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bronchiectasis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Amikacin Sulfate Consumption and Growth Rate (2017-2022)
-
Figure Global ARD-3150 Consumption and Growth Rate (2017-2022)
-
Figure Global CHF-6333 Consumption and Growth Rate (2017-2022)
-
Figure Global Ciprofloxacin Hydrochloride Consumption and Growth Rate (2017-2022)
-
Figure Global Doxofylline Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Homecare Consumption and Growth Rate (2017-2022)
-
Figure Global Amikacin Sulfate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ARD-3150 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CHF-6333 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ciprofloxacin Hydrochloride Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Doxofylline Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Homecare Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Bronchiectasis Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Bronchiectasis Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Alitair Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Alitair Pharmaceuticals Inc Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alitair Pharmaceuticals Inc Bronchiectasis Treatment Product and Service
-
Table Grifols SA (Foundation Year, Company Profile and etc.)
-
Table Grifols SA Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols SA Bronchiectasis Treatment Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Bronchiectasis Treatment Product and Service
-
Table Chiesi Farmaceutici SpA (Foundation Year, Company Profile and etc.)
-
Table Chiesi Farmaceutici SpA Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chiesi Farmaceutici SpA Bronchiectasis Treatment Product and Service
-
Table Recipharm AB (Foundation Year, Company Profile and etc.)
-
Table Recipharm AB Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Recipharm AB Bronchiectasis Treatment Product and Service
-
Table Insmed Inc (Foundation Year, Company Profile and etc.)
-
Table Insmed Inc Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Insmed Inc Bronchiectasis Treatment Product and Service
-
Table Kamada Ltd (Foundation Year, Company Profile and etc.)
-
Table Kamada Ltd Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kamada Ltd Bronchiectasis Treatment Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Bronchiectasis Treatment Product and Service
-
Table Polyphor Ltd (Foundation Year, Company Profile and etc.)
-
Table Polyphor Ltd Bronchiectasis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Polyphor Ltd Bronchiectasis Treatment Product and Service
-
